ZMYND11 has also been proposed to be an inhibitor of transcriptional pause release in a cancer cell line, as shRNA-mediated knockdown of ZMYND11 in U2OS cells leads to an increase in the occupancy of RNA Polymerase II at gene bodies relative to the promoter of upregulated genes23. Here, ZMYND11 is linked to cancer.